(RTTNews) - French drug major Sanofi (SNYNF, SNY) announced Monday positive results of Dupixent (dupilumab) Phase 3 trial in chronic obstructive pulmonary disease or COPD. In the second Dupixent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results